Cargando…
Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals
In March 2020, the World Health Organization (WHO) declared a global health emergency—the coronavirus disease 2019 (COVID-19) pandemic. Since then, the development and implementation of vaccines against the virus amidst emerging cases of re-infection has prompted researchers to work towards understa...
Autores principales: | Casian, Joseph G., Angel, Aaron N., Lopez, Ronell, Bagos, Cedie, MacMullan, Melanie A., Bui, Mindy L., Chellamathu, Prithivi, Das, Sudipta, Turner, Fred, Slepnev, Vladimir, Ibrayeva, Albina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446671/ https://www.ncbi.nlm.nih.gov/pubmed/34539632 http://dx.doi.org/10.3389/fimmu.2021.701411 |
Ejemplares similares
-
ELISA detection of SARS-CoV-2 antibodies in saliva
por: MacMullan, Melanie A., et al.
Publicado: (2020) -
Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device
por: MacMullan, Melanie A., et al.
Publicado: (2021) -
SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals
por: Chellamuthu, Prithivi, et al.
Publicado: (2021) -
Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination
por: Mades, Aubree, et al.
Publicado: (2021) -
Unique immune and inflammatory cytokine profiles may define long COVID syndrome
por: Allan-Blitz, Lao-Tzu, et al.
Publicado: (2023)